Press/Media
- 1 - 25 out of 42 results
Search results
-
João Pedro Martins, PhD student in Prof. Santos' Lab, receives the Controlled Release Society Focus Group in Oral Drug Delivery Trainee Award
Martins, J. P.
08/07/2021
1 item of Media coverage
Press/Media: Press / Media
-
Microneedles for cancer immunotherapy may lead to minimal invasiveness, side effects
06/05/2021
5 items of Media coverage
Press/Media: Press / Media
-
-UNIVERSITY OF HELSINKI: Microneedles are promising devices for painless drug delivery with minimal side effects
Fontana, F.
05/05/2021
1 item of Media coverage
Press/Media: Press / Media
-
Microneedles are promising devices for painless drug delivery with minimal side effects
Santos, H. A. & Fontana, F.
04/05/2021 → 05/05/2021
6 items of Media coverage
Press/Media: Press / Media
-
Recently published book on “Nanotechnology for Oral Drug Delivery” by João Martins and Prof. Hélder Santos
Martins, J. P.
13/11/2020
1 item of Media coverage
Press/Media: Press / Media
-
Prof. Santos' PhD student, João Martins, won the best Oral Presentation at the NSENANO2020 conference in Chieti
Martins, J. P.
17/01/2020
1 item of Media coverage
Press/Media: Press / Media
-
-University of Helsinki: Advanced viral nanovaccine for cancer immunotherapy
Fontana, F.
18/12/2019
1 item of Media coverage
Press/Media: Press / Media
-
Advanced viral nanovaccine for cancer immunotherapy
Fontana, F. & Santos, H. A.
17/12/2019
4 items of Media coverage
Press/Media: Press / Media
-
-
-
Finnish-Chinese nanomedicine research shows potential for cancer treatment
23/09/2019
1 item of Media coverage
Press/Media: Press / Media
-
Novel Anti-Cancer Nanomedicine for Efficient Chemotherapy
17/09/2019 → 18/09/2019
2 items of Media coverage
Press/Media: Press / Media
-
New Cell-based Nanomedicine Makes Chemotherapy Efficient
18/09/2019
1 item of Media coverage
Press/Media: Press / Media
-
Novel Anti-cancer Nanomedicine for Efficient Chemotherapy
18/09/2019
1 item of Media coverage
Press/Media: Press / Media
-
Novel anti-cancer nanomedicine for efficient chemotherapy
17/09/2019 → 18/09/2019
7 items of Media coverage
Press/Media: Press / Media
-
Researchers develop new anti-cancer nanomedicine for targeted chemotherapy
17/09/2019
1 item of Media coverage
Press/Media: Press / Media
-
Novel anticancer nanomedicine for efficient chemotherapy
15/09/2019
1 item of Media coverage
Press/Media: Press / Media
-
Novel anti-cancer nanomedicine for efficient chemotherapy
13/09/2019
1 item of Media coverage
Press/Media: Press / Media
-
New nanomedicine for efficient cancer chemotherapy
13/09/2019
1 item of Media coverage
Press/Media: Press / Media
-
PhD student of Prof. Santos' Lab, João Martins, wins the Controlled Release Society Mind Mapping Championship 2019
Martins, J. P.
05/09/2019
1 item of Media coverage
Press/Media: Press / Media
-
-UNIVERSITY OF HELSINKI: Personalized nanovaccines are safe, well tolerated, and have an effect in melanoma
Fontana, F.
14/06/2019
1 item of Media coverage
Press/Media: Press / Media
-
Personalized nanovaccines are safe, well tolerated, and have an effect in melanoma
Fontana, F. & Santos, H. A.
13/06/2019
1 item of Media coverage
Press/Media: Press / Media
-
Prof. Santos' PhD student, João Martins, won the best 3MT pitch at the Annual FinPharmaNet meeting in Turku
Martins, J. P.
07/06/2019
1 item of Media coverage
Press/Media: Press / Media
-
PhD student of Prof. Santos' Lab, João Martins, featured the CRS OrDD Trainee of the Month for March
Martins, J. P.
27/03/2019
1 item of Media coverage
Press/Media: Press / Media
-
Communicating science to the general public
Martins, J. P.
27/03/2019
1 item of Media coverage
Press/Media: Press / Media